What's new

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 9, Status: Authorised

Mar 3, 2025 - 17:37
 0
Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Fymskina, ustekinumab,...

Next Article

Human medicines European public assessment report (EPAR): Clopidogrel / Acetylsa...

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Xydalba, dalbavancin hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0467/2023

Opinion/decision on a Paediatric investigation plan (PI...

Mar 6, 2025  0

EMEA-002951-PIP02-21

EMEA-002951-PIP02-21

Mar 17, 2025  0

Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 10, 2025  0